On January 7, 2019 Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, reported that it will webcast its presentation at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 (Press release, Theravance, JAN 7, 2020, View Source [SID1234552815]). The presentation is scheduled for 8:30 a.m. PT (11:30 a.m. ET/4:30 p.m. GMT) and may be accessed by visiting the Investor Relations section of Theravance Biopharma’s website at www.theravance.com, under the Presentations and Events tab.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Listeners are encouraged to visit the site at least 15 minutes prior to the scheduled presentation to register, download and install any necessary audio software. Audio replays will be available for 30 days following the presentation.